Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil

Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02283-6. Online ahead of print.
No abstract available

Publication types

  • Letter